EN DE
Watch Ever Fortune.AI Co. Ltd. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Ever Fortune.AI Co. Ltd. (6841) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Ever Fortune.AI Co. Ltd. stock TWD 12.67, price TWD 48.50, that is 73.9% below the price, quality 58 out of 100. Rating: strongly overvalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare TW

EF Ever Fortune.AI Co. Ltd. logo Some data Nov 4, 2026

Ever Fortune.AI Co. Ltd.

6841 · TWO
Very expensive, in a downtrend

Our calculation puts a fair price 74% below what the stock costs today.

Solidly profitable · 16.8% net margin (TTM)
Profit last quarter +44% vs. a year ago.
Quality 58/100
Expensive Growth (revenue 5y +155.4 %/yr in TWD)
Mixed vs. peers (5/12)
Moderate moat 53/100 · thin data
Some data
Fair value 12.67 TWD · Strongly overvalued
Negative free cash flow
Watch Ever Fortune.AI Co. Ltd. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

191.16 TWD 48.50 TWD Fair Value 12.67 TWD Sep 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range 48.50 TWD – 191.16 TWD · fair‑value band 11.25 TWD – 13.09 TWD · the 48.50 TWD price screens above the 12.67 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow Ever Fortune.AI Co. in your weekly email

Every Wednesday you see whether Ever Fortune.AI Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China.

Show moreShow less

The company offers radiation therapy organ, head and neck organ delineation system, bone scintigraphy computer-aided detection platform, cerebral hemorrhage detection system, myocardial perfusion image analysis and reporting system, ECG analysis software, acute aortic syndrome, detection system, acute myocardial infarction detection software, heart-to-chest ratio estimation system, artificial intelligence assisted chest X-ray diagnosis system, bone age auxiliary diagnosis system, and image recording and transmission system.

Ever Fortune.AI Co., Ltd. was founded in 1998 and is based in Taichung, Taiwan. Ever Fortune.AI Co., Ltd. is a subsidiary of An Ji Biomedical Corporation.

Stock analysis

Ever Fortune.AI Co. Ltd. (6841) currently trades at 48.50 TWD, while our model-based Fair Value estimate is 12.67 TWD, 74% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 44.60 TWD per share, and 1 of the 17 models we run sit above the 48.50 TWD price.

Bear case: the Asset-Based group reads lowest at 7.42 TWD, and 16 of the 17 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 11.25 TWD (bear) to 13.09 TWD (bull), the price of 48.50 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Ever Fortune.AI Co. Ltd. reported revenue of 379M TWD in FY2025 versus 38.2M TWD in FY2021, a compound +77.4%/yr. Reported net income was 83.4M TWD in FY2025.

Key figures

Market cap 4.7B TWD (≈ $143M) Micro · P/E ratio 70.3 · P/S ratio 15.8 · EPS (TTM) 0.6900 TWD · Dividend yield 1.9% · Net margin 16.8% · Return on equity 3.5% · Return on assets (EBIT) 1.0% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 53 out of 100 (low confidence).

What moves the price

The share trades about 31% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 3% fair-value upside, at −74%, 6841 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (5.99 TWD to 70.08 TWD). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 11.25 TWD Fair Value 12.67 TWD Bull 13.09 TWD
Price 48.50 TWD · Downside -73.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.5917 TWD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income 12.68 TWD 12.67 TWD 13.09 TWD 74
Owner Earnings 6.62 TWD 8.84 TWD 12.83 TWD 71
EPV 6.57 TWD 6.84 TWD 7.07 TWD 69
All 17 models by family
DCF Models
Owner Earnings 6.62 TWD 8.84 TWD 12.83 TWD 71
Earnings-Based
Graham-Dodd 6.00 TWD 41.85 TWD 58.73 TWD 61
Lynch FV 21.62 TWD 30.89 TWD 40.15 TWD 59
PEG = 1.0 21.62 TWD 30.89 TWD 40.15 TWD 55
EPV 6.57 TWD 6.84 TWD 7.07 TWD 69
Dividend Discount
Gordon GGM 5.76 TWD 9.96 TWD 13.25 TWD 66
DDM Multi-Stage 5.76 TWD 9.29 TWD 10.68 TWD 65
Multiples
P/E Multiple 18.53 TWD 24.71 TWD 30.89 TWD 63
P/S Multiple 11.25 TWD 15.00 TWD 18.75 TWD 57
P/B Multiple 52.56 TWD 70.08 TWD 87.60 TWD 55
EV/EBIT 7.58 TWD 9.48 TWD 11.38 TWD 62
EV/EBITDA 8.69 TWD 10.96 TWD 13.23 TWD 64
EV/Revenue 4.76 TWD 5.99 TWD 7.23 TWD 51
Asset-Based
NCAV (Graham) 4.89 TWD 7.42 TWD 9.27 TWD 52
Economic Profit
Residual Income 12.68 TWD 12.67 TWD 13.09 TWD 74
ROIC Compounder 6.57 TWD 6.84 TWD 7.07 TWD 67
Growth Earnings
Growth-Adj P/E 31.22 TWD 44.60 TWD 57.98 TWD 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 58/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 36
How much profit the company makes from its sales and capital
Quality Growth 64
Are margins and returns getting better?
Cashflow 13
Do the profits arrive as real cash?
Financial strength 97
Debt, balance sheet and risk of trouble
Investment 52
Does it invest with discipline instead of growing at any price?
Low Volatility 84
How calm the share price moves, does not count
Price momentum 22
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 81
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 57/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+12.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+91.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+155.4%
Start year 2020 (pandemic)
What shareholders gained per year (last 3 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−15.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−16.9%
Dividend (yield on the price)1.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−1,941% → 10%

6841 screens overvalued: fair value 74% below the price. Compare with Veeva Systems Inc →

Compare Ever Fortune.AI Co. Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 117 stocks

Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside −73.9% · Bottom 25%
Profitability
Return on equity (12 months) 3.5% · Above median
Return on assets 5.1% · Above median
Net margin (12 months) 21.6% · Top 25%
Operating margin (12 months) 20.4% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 7.1% · Below median
Dividend yield (12 months) 1.9% · Below median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (12 months) 70.3× · Priciest 25%
P/B 2.80× · Pricier than median
P/S (12 months) 15.80× · Priciest 25%
EV/EBITDA 80.8× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 5
FUTURE (revenue growth)36 · sector 46
PAST (return on equity)14 · sector 10
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)37 · sector 41

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Veeva Systems Inc VEEV $303.73 $334.10 +10% vs 6841
HealthEquity, Inc HQY $103.63 $113.99 +10% vs 6841
Doximity, Inc DOCS $32.51 $35.76 +10% vs 6841
Inventurus Knowledge Solutions Limited IKS ₹1,657 ₹1,823 +10% vs 6841
Waystar Holding WAY $28.35 $29.10 +3% vs 6841
Hinge Health, Inc HNGE $115.76 $51.25 −56% vs 6841
Pro Medicus Limited PME A$205.49 A$85.12 −59% vs 6841
BrightSpring Health Services, Inc BTSG $67.15 $25.72 −62% vs 6841
XtalPi Holdings 2228 HK$6.13 HK$1.53 −75% vs 6841
Privia Health Group PRVA $24.42 $5.52 −77% vs 6841

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Ever Fortune.AI Co. Ltd.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Ever Fortune.AI Co. Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6841

Frequently asked questions

Is Ever Fortune.AI Co. Ltd. (6841) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 12.67 TWD versus a price of 48.50 TWD, about 74% lower (overvalued).
What is the fair value of 6841?
Our model-based fair value for Ever Fortune.AI Co. Ltd. is 12.67 TWD (as of Nov 4, 2026), built from audited fundamentals. The current price: 48.50 TWD.
What is the quality score of 6841?
Ever Fortune.AI Co. Ltd. has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Ever Fortune.AI Co. Ltd. (6841)?
Our model-based price target is the fair value of 12.67 TWD (as of Nov 4, 2026) from 17 valuation models. Cautious scenario 11.25 TWD, optimistic scenario 13.09 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Ever Fortune.AI Co. Ltd. stock forecast for 2026?
Our models put fair value at 12.67 TWD, about 74% lower versus a price of 48.50 TWD (overvalued). Cautious scenario 11.25 TWD, optimistic scenario 13.09 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Ever Fortune.AI Co. Ltd. (6841)?
Ever Fortune.AI Co. Ltd. reported trailing-twelve-month revenue of about 383M TWD (latest available figure, as of Nov 4, 2026).
Does Ever Fortune.AI Co. Ltd. pay a dividend?
Ever Fortune.AI Co. Ltd. currently shows a dividend yield of 1.86% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Ever Fortune.AI Co. Ltd. (6841)?
Ever Fortune.AI Co. Ltd. has a dividend yield of 1.9%.
What is the intrinsic value of Ever Fortune.AI Co. Ltd. (6841)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Ever Fortune.AI Co. Ltd. it is 12.67 TWD per share (as of Nov 4, 2026), against a price of 48.50 TWD. It is the blended result of 17 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Ever Fortune.AI Co. Ltd. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 6841 trades above its calculated fair value: price 48.50 TWD, fair value 12.67 TWD, a gap of about −74% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6841?
No. The price is what the market pays today (48.50 TWD); the fair value is what the company's own numbers justify (12.67 TWD). For Ever Fortune.AI Co. Ltd. the two are 35.83 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Ever Fortune.AI Co. Ltd. worth?
The market values Ever Fortune.AI Co. Ltd. at about 4.7B TWD (market capitalisation, as of Nov 4, 2026). Per share that is 48.50 TWD; our models calculate a fair value of 12.67 TWD per share.
What do the bullish and bearish scenarios say about 6841?
Our models span a range for Ever Fortune.AI Co. Ltd.: cautious scenario 11.25 TWD, base 12.67 TWD, optimistic 13.09 TWD per share (as of Nov 4, 2026, price 48.50 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6841?
Ever Fortune.AI Co. Ltd. trades at a price-to-earnings ratio of 70.3 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 12.67 TWD is built from several models across several years. Other multiples: P/B 2.8, P/S 15.8, EV/EBITDA 80.8.
How solid is the balance sheet of Ever Fortune.AI Co. Ltd. (6841)?
Balance-sheet figures for Ever Fortune.AI Co. Ltd. (as of Nov 4, 2026): return on equity 3.5%. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 6841 from its 52-week high?
Ever Fortune.AI Co. Ltd. trades at 48.50 TWD, about 31% below its 52-week high of 70.02 TWD and at the low of 48.50 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 12.67 TWD is for.
Which stocks are comparable to Ever Fortune.AI Co. Ltd.?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Ever Fortune.AI Co. Ltd. stock attractive at the current price?
The data as of Nov 4, 2026: price 48.50 TWD, calculated fair value 12.67 TWD (−74%), Quality Score 58/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6841 calculated?
We run Ever Fortune.AI Co. Ltd. through 17 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 12.67 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Ever Fortune.AI Co. Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Ever Fortune.AI Co. Ltd. (6841)?
The closing price on Nov 6, 2026 was 48.50 TWD. Our model-based fair value is 12.67 TWD, about 74% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Ever Fortune.AI Co. Ltd. right now?
The price sits above even our optimistic bull case (13.09 TWD). The favourable scenario is already priced in. Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Ever Fortune.AI Co. Ltd.

How large is the market capitalisation of Ever Fortune.AI Co. Ltd. (6841)?
The market capitalisation of Ever Fortune.AI Co. Ltd. is 4.7B TWD (≈ $143M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Ever Fortune.AI Co. Ltd. (6841)?
The price-to-sales ratio of Ever Fortune.AI Co. Ltd. is 15.8 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Ever Fortune.AI Co. Ltd. (6841)?
Earnings per share at Ever Fortune.AI Co. Ltd. are 0.6900 TWD (price ÷ EPS = P/E 70.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Ever Fortune.AI Co. Ltd. (6841)?
The dividend yield of Ever Fortune.AI Co. Ltd. is 1.9% (payout 130%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Ever Fortune.AI Co. Ltd. (6841)?
The net margin of Ever Fortune.AI Co. Ltd. is 16.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Ever Fortune.AI Co. Ltd. (6841)?
The return on equity (ROE) of Ever Fortune.AI Co. Ltd. is 3.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Ever Fortune.AI Co. Ltd. (6841)?
On an EBIT basis the return on assets of Ever Fortune.AI Co. Ltd. is 1.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Ever Fortune.AI Co. Ltd. (6841)?
The operating margin of Ever Fortune.AI Co. Ltd. is 20.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Ever Fortune.AI Co. Ltd. (6841)?
Revenue at Ever Fortune.AI Co. Ltd. is growing +7.1% versus a year earlier (3y avg +91.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Ever Fortune.AI Co. Ltd. (6841)?
Earnings per share at Ever Fortune.AI Co. Ltd. are growing +43.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Ever Fortune.AI Co. Ltd. (6841) generate?
The free cash flow of Ever Fortune.AI Co. Ltd. is −30.2M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Ever Fortune.AI Co. Ltd. (6841) hold?
Ever Fortune.AI Co. Ltd. holds more cash than debt, 228M TWD net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Ever Fortune.AI Co. Ltd. in the live analysis

One click puts Ever Fortune.AI Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.